Navigation Links
Luis Tiant and Sunridge International Partner to Provide Medical Relief in Cuba: Former Star Pitcher for the Red Sox and Yankees Leads the Fight Against Glaucoma
Date:2/2/2010

FOUNTAIN HILLS, Ariz., Feb. 2 /PRNewswire-FirstCall/ -- Sunridge International (OTC Bulletin Board: SNDZ), an innovative developer of safe and noninvasive therapies for glaucoma, proudly announces its partnership with Luis Tiant and Scientific Social Solutions Charitable Foundation (S3) to provide medical relief in Cuba. Tiant, a Cuban native and former starting pitcher for the Boston Red Sox and New York Yankees, will work in conjunction with the Scientific Social Solutions Charitable Foundation and Ophthalmic International (www.oi-pnt.com), a wholly owned subsidiary of Sunridge, to help Cubans fight glaucoma.

Sunridge will send a medical team to Cuba to train doctors and treat patients, followed by a shipment of supplies to a distribution center to help patients after the team leaves the island. Glaucoma is the 2nd leading cause of blindness in Cuba, an issue Mr. Tiant will promote as the spokesperson for this charity drive.

Ophthalmic International has pioneered Pneumatic Trabeculoplasty (PNT), a two-minute, noninvasive, cost effective, alternative treatment for glaucoma. This treatment is ideal for Cuba and other countries' national health care systems because PNT is safe; and the treatment lasts 3-4 months before another round of care is necessary.  

"I'm very excited about being a partner with Sunridge and Ophthalmic International in this medical relief program for Cuba. I know that glaucoma is an incredibly serious problem not only in Cuba but everywhere, and it is always good to be able to give something back," states Luis Tiant.

Credibility and Success Worldwide: Sunridge International in Action

Sunridge International continues to champion PNT and combat glaucoma. "We're extremely pleased with our involvement with Luis Tiant and this project. It will not only help the citizens of Cuba, but will most likely start a domino effect in the Caribbean, because of the fact that 'PNT' provides a safe, affordable and effective treatment for glaucoma patients everywhere," says G. Richard Smith, President and CEO of Sunridge International.

About Sunridge International

Headquartered in Fountain Hills, Arizona, Sunridge International (www.sunridgeint.com) is an innovative developer of Pneumatic Trabeculoplasty (PNT), a safe, noninvasive therapy for glaucoma. Through its wholly owned subsidiary, Ophthalmic International, the company manufactures a vacuum fixation device and a patented design suction ring for the treatment of open angle glaucoma.

Forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995.  Investors are cautioned that such forward-looking statements involve risks and uncertainties, including without limitation, continued acceptance of the company's products, increased levels of competition for the company, new products and technological changes, the company's dependence on third-party suppliers, and other risks detailed from time to time in the company's periodic reports filed with the Securities and Exchange Commission.

Contact: Jeff Smith, +1-480-837-6165, info@sunridgeint.com

SOURCE Sunridge International

RELATED LINKS
http://www.sunridgeint.com

'/>"/>

SOURCE Sunridge International
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. International study strengthens case for daily calcium pill
2. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
3. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
4. LCA Hails International Investigators Studying Lung Cancer
5. Arrow International Urges Shareholders To Vote for Approval of the $45.50 Teleflex Inc. Merger and for the Current Board of Directors
6. PRA International Adds Dr. Susan Stansfield as Executive Vice President
7. Medical Services International Maintains Pace in Second Quarter
8. Clarity Imaging International, Inc. Rolls Out Mobile DEXA Program
9. International Gateway Insurance Brokers Partners With MEDILINQ
10. Tulane University to receive $14M for international HIV/AIDS program
11. International Database Seeks to Boost Treatment of Altitude Sickness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... people are unfamiliar with. The article goes on to state that individuals are now ... of these less common operations such as calf and cheek reduction. The Los Angeles ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, ... at his family verbally and physically. , “When something upset him, he couldn’t control his ... it. He would throw rocks at my other children and say he was going to ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas ... , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening their pencils ... an essay contest in which patients and their families pay tribute to a genetic ... 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® ... Group (TGIG), has initiated cultivation and processing operations at its production facility, and ... Nevada. , Puradigm is the manufacturer of a complete system of proactive air ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
(Date:6/24/2016)... , June 24, 2016 The Academy ... of recommendations that would allow biopharmaceutical companies ... with entities that make formulary and coverage decisions, a ... "value" of new medicines. The recommendations address ... not appear on the drug label, a prohibition that ...
(Date:6/24/2016)... India , June 24, 2016 ... Needles Market by Type (Standard Pen Needles, Safety Pen ... Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, ... by MarketsandMarkets, This report studies the market for the ... expected to reach USD 2.81 Billion by 2021 from ...
Breaking Medicine Technology: